Hilltop Holdings’s Microbot Medical MBOT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$43.8K Buy
36,464
+700
+2% +$1.13K ﹤0.01% 662
2026
Q2
$69.7K Hold
35,764
– – 0.01% 675
2026
Q1
$86.2K Hold
35,764
– – 0.01% 633
2025
Q4
$71.5K Hold
35,764
– – ﹤0.01% 877
2025
Q3
$109K Buy
35,764
+2,076
+6% +$6.48K 0.01% 898
2025
Q2
$84.9K Sell
33,688
-1
-0% -$2 0.01% 853
2025
Q1
$50.9K Hold
33,689
– – ﹤0.01% 839
2024
Q4
$37.7K Buy
33,689
+3,000
+10% +$2.93K ﹤0.01% 834
2024
Q3
$27.4K Buy
30,689
+5,250
+21% +$5.12K ﹤0.01% 819
2024
Q2
$25.9K Sell
25,439
-750
-3% -$771 ﹤0.01% 598
2024
Q1
$32.2K Buy
26,189
+5,850
+29% +$7.42K ﹤0.01% 623
2023
Q4
$33.4K Buy
20,339
+1,264
+7% +$1.68K ﹤0.01% 585
2023
Q3
$26.5K Hold
19,075
– – ﹤0.01% 576
2023
Q2
$51.9K Buy
+19,075
New +$38.2K 0.01% 558

Other funds holding MBOT

Hilltop Holdings's MBOT Position: Q3 2026 in Review

Hilltop Holdings increased its Microbot Medical (MBOT) stake by 2% in Q3 2026, buying an estimated $1.13K and bringing the position to 36,464 shares worth $43.8K. The position accounts for ﹤0.01% of the portfolio, ranked #662.

Hilltop Holdings first reported a position in MBOT in Q2 2023 and has held it in 14 quarters since. The position peaked at $109K in Q3 2025. 72 funds tracked by Wall St. Rank hold MBOT as of Q3 2026.

  • Hilltop Holdings held 36,464 shares of Microbot Medical worth $43.8K as of Q3 2026.
  • Hilltop Holdings bought 700 Microbot Medical shares in Q3 2026, an estimated $1.13K.
  • Microbot Medical made up ﹤0.01% of Hilltop Holdings's portfolio in Q3 2026, its #662 holding.
  • Hilltop Holdings first reported a position in Microbot Medical in Q2 2023 and has held it in 14 quarters since.
  • Hilltop Holdings's Microbot Medical position peaked at $109K in Q3 2025.
  • 72 funds tracked by Wall St. Rank held Microbot Medical as of Q3 2026.

Based on Hilltop Holdings's 13F filing for Q3 2026, filed 16 Nov 2026.